Keywords: strong, ph, ii, data, inspire, allergy, nasal

Strong Ph II data for Inspire's allergy nasal spray

Article | 14 May 2007

Print This

The USA's Inspire Pharmaceuticals says that, in a Phase II dose-ranging clinical trial in seasonal allergic rhinitis, its epinastine nasal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in